Changeflow GovPing Healthcare National Heart, Lung, and Blood Institute Notic...
Routine Notice Added Final

National Heart, Lung, and Blood Institute Notice of Meeting

Favicon for www.federalregister.gov FR: National Institutes of Health
Published
Detected
Email

Summary

The National Heart, Lung, and Blood Institute (NHLBI), part of the NIH, published a Federal Register Notice on April 14, 2026 announcing a public meeting scheduled for May 26, 2026. This notice satisfies requirements under the Federal Advisory Committee Act for public disclosure of advisory committee meetings. No regulatory obligations or compliance deadlines are established by this document.

What changed

NHLBI published a one-page Federal Register Notice announcing a public meeting scheduled for May 26, 2026. This is a routine procedural document required under the Federal Advisory Committee Act to provide public notice of government advisory meetings.

Healthcare providers, researchers, and stakeholders interested in heart, lung, and blood research should monitor subsequent Federal Register publications for the full meeting agenda, virtual participation links, and any pre-registration requirements. This notice does not impose compliance obligations or deadlines on affected parties.

What to do next

  1. Monitor the Federal Register for additional meeting details and agenda

Archived snapshot

Apr 14, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Legal Status This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.

The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to About the Federal Register on NARA's archives.gov.

The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.

Legal Status

Notice

National Heart, Lung, And Blood Institute; Notice of Meeting

A Notice by the National Institutes of Health on 04/14/2026

  • 1.

1.

  • Document Details Published Content - Document Details Agencies Department of Health and Human Services National Institutes of Health Document Citation 91 FR 19144 Document Number 2026-07150 Document Type Notice Page 19144
    (1 page) Publication Date 04/14/2026 Published Content - Document Details

  • PDF Official Content

  • Document Details Published Content - Document Details Agencies Department of Health and Human Services National Institutes of Health Document Citation 91 FR 19144 Document Number 2026-07150 Document Type Notice Page 19144
    (1 page) Publication Date 04/14/2026 Published Content - Document Details

  • Document Dates Published Content - Document Dates Dates Text May 26, 2026. Published Content - Document Dates

  • Table of Contents Enhanced Content - Table of Contents This table of contents is a navigational tool, processed from the
    headings within the legal text of Federal Register documents.
    This repetition of headings to form internal navigation links
    has no substantive legal effect.

There is no table of contents available for this document. Enhanced Content - Table of Contents

  • Public Comments Enhanced Content - Public Comments This feature is not available for this document.

Enhanced Content - Public Comments
- Regulations.gov Data Enhanced Content - Regulations.gov Data Additional information is not currently available for this document.

Enhanced Content - Regulations.gov Data

- Sharing Enhanced Content - Sharing Shorter Document URL https://www.federalregister.gov/d/2026-07150 Email Email this document to a friend Enhanced Content - Sharing

  • Print Enhanced Content - Print
  • Other Formats Enhanced Content - Other Formats This document is also available in the following formats:

JSON Normalized attributes and metadata XML Original full text XML MODS Government Publishing Office metadata More information and documentation can be found in our developer tools pages.

Enhanced Content - Other Formats
- Public Inspection Public Inspection This PDF is FR Doc. 2026-07150 as it appeared on Public Inspection on
04/13/2026 at 8:45 am.

It was viewed
20
times while on Public Inspection.

If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507.
Learn more here.

Public Inspection
Published Document: 2026-07150 (91 FR 19144) This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Document Headings Document headings vary by document type but may contain
the following:

  1. the agency or agencies that issued and signed a document
  2. the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
  3. the agency docket number / agency internal file number
  4. the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details.
Department of Health and Human Services
National Institutes of Health

( printed page 19144) Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Sickle Cell Disease Advisory Committee.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov/​watch/​d3614358-26f0-11f1-9f14-124f0a52e769).

Name of Committee: Sickle Cell Disease Advisory Committee (SCDAC).

Date: May 26, 2026.

Time: 11:00 a.m. to 4:00 p.m.

Agenda: Nutrition in Sickle Cell Disease.

Address: National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20892.

Meeting Format: Virtual Meeting.

Contact Person: Julie A Panepinto, MD, MSPH, Professor, DFO/Executive Secretary, SCDAC, Division of Blood Diseases and Resources, 6701 Rockledge Drive, Suite 9166, Bethesda, MD 20892, (301) 435-0080, Julie.panepinto@nih.gov.

Registration is not required to attend the open portion of this meeting.

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

Information is also available on the Institute's/Center's home page: https://www.nhlbi.nih.gov/​advisory-and-peer-review-committees/​nhlbi-sickle-cell-disease-advisory-committee, where an agenda and any additional information for the meeting will be posted when available.

Dated: April 9, 2026.

Denise M. Santeufemio,

Supervisory Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2026-07150 Filed 4-13-26; 8:45 am]

BILLING CODE 4140-01-P

Published Document: 2026-07150 (91 FR 19144)

Get daily alerts for FR: National Institutes of Health

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from Health and Human Services Department.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
Health and Human Services Department
Published
April 14th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
91 FR 19144
Docket
2026-07150

Who this affects

Applies to
Healthcare providers Patients Public health authorities
Industry sector
6211 Healthcare Providers
Activity scope
Medical research Federal advisory meetings Public health
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Regulatory Affairs
Topics
Public Health Pharmaceuticals

Get alerts for this source

We'll email you when FR: National Institutes of Health publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!